Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Rice

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Infectious Diseases|August 1, 1990
Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysisM A Apicella, R E Mandrell, M Shero, et al.
The Journal of Biological Chemistry|April 18, 1997
Structure of the monophosphoryl lipid A moiety obtained from the lipopolysaccharide of Chlamydia trachomatisN Qureshi, I Kaltashov, K Walker, et al.
Neurology|March 29, 2006
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapsesP W O'Connor, D Li, M S Freedman, et al.
American Journal of Epidemiology|January 1, 1974
An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccinesM M Levine, P A Rice, E J Gangarosa, et al.
The Journal of Experimental Medicine|February 7, 2001
Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeaeS Ram, M Cullinane, A M Blom, et al.
International Immunopharmacology|May 23, 2001
C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeaeS Ram, M Cullinane, A M Blom, et al.
Molecular Immunology|March 4, 2000
The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidisS Ram, F G Mackinnon, S Gulati, et al.
American Journal of Obstetrics and Gynecology|March 1, 1997
Oral contraception and the recognition of endometritisR B Ness, L M Keder, D E Soper, et al.
The New England Journal of Medicine|January 3, 2003
A controlled trial of natalizumab for relapsing multiple sclerosisDavid H Miller, Omar A Khan, William A Sheremata, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS studyM S Freedman, G S Francis, E A C M Sanders, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Infectious Diseases|August 1, 1990
Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysisM A Apicella, R E Mandrell, M Shero, et al.
The Journal of Biological Chemistry|April 18, 1997
Structure of the monophosphoryl lipid A moiety obtained from the lipopolysaccharide of Chlamydia trachomatisN Qureshi, I Kaltashov, K Walker, et al.
Neurology|March 29, 2006
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapsesP W O'Connor, D Li, M S Freedman, et al.
American Journal of Epidemiology|January 1, 1974
An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccinesM M Levine, P A Rice, E J Gangarosa, et al.
The Journal of Experimental Medicine|February 7, 2001
Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeaeS Ram, M Cullinane, A M Blom, et al.
International Immunopharmacology|May 23, 2001
C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeaeS Ram, M Cullinane, A M Blom, et al.
Molecular Immunology|March 4, 2000
The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidisS Ram, F G Mackinnon, S Gulati, et al.
American Journal of Obstetrics and Gynecology|March 1, 1997
Oral contraception and the recognition of endometritisR B Ness, L M Keder, D E Soper, et al.
The New England Journal of Medicine|January 3, 2003
A controlled trial of natalizumab for relapsing multiple sclerosisDavid H Miller, Omar A Khan, William A Sheremata, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS studyM S Freedman, G S Francis, E A C M Sanders, et al.
Pageof 12